Propranolol is efficacious against Aspergillus and Fusarium corneal isolates in vitro and in a murine model of Aspergillus keratitis
Antimicrobial Agents and Chemotherapy · 2025
DOI: 10.1128/aac.01664-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Michael E Zegans und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA. Hauptthemen laut MEDLINE: Adrenergic beta-Antagonists, Antifungal Agents, Aspergillosis, Aspergillus fumigatus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, NIGMS NIH HHS, Research to Prevent Blindness.
Abstract (Originalsprache)
Fungal keratitis is a severe corneal infection most commonly caused by filamentous fungi. Even with prompt treatment with current antifungals, it often results in corneal perforation and blindness. In this report, we observe that the beta-adrenergic antagonist, propranolol, displays antifungal activity against Aspergillus and Fusarium corneal isolates in vitr o and strikingly blocks disease establishment in a murine model of Aspergillus fumigatus keratitis. These findings suggest that beta-blockers have potential as a novel FK treatment. CLINICAL TRIALS This study is registered with ClinicalTrials.gov as NCT00997035 (MUTT Trial).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
- Department of Surgery, Section of Ophthalmology, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA.
- Deparment of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
- Department of Ophthalmology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
- Department of Biology, Lawrence University, Appleton, Wisconsin, USA.
- Department of Cornea, Aravind Eye Hospital, Madurai, India.
ORCID-Profile: Michael E Zegans, Cecilia Gutierrez-Perez, Emily M Adams, Robert A Cramer, Kevin K Fuller
Förderung
- NEI NIH HHS
- NIGMS NIH HHS
- Research to Prevent Blindness
- National Institute of Allergy and Infectious Diseases
- National Heart Lung & Blood Institute
- NIAID NIH HHS
- Cystic Fibrosis Foundation
- NHLBI NIH HHS
Zitieren
APA
Zegans, M. E., Kamath, M. M., Jones, J. T., Bao, R., Ross, B. S., Gutierrez-Perez, C., Adams, E. M., Lightfoot, J. D., Poimenidou, G., Pavuluri, C., Prajna, V., Cramer, R. A., & Fuller, K. K. (2025). Propranolol is efficacious against Aspergillus and Fusarium corneal isolates in vitro and in a murine model of Aspergillus keratitis. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01664-24
Vancouver
Zegans ME, Kamath MM, Jones JT, Bao R, Ross BS, Gutierrez-Perez C, et al. Propranolol is efficacious against Aspergillus and Fusarium corneal isolates in vitro and in a murine model of Aspergillus keratitis. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.01664-24
BibTeX
@article{Zegans2025,
author = {Zegans, Michael E and Kamath, Manali M and Jones, Jane T and Bao, Ruina and Ross, Brandon S and Gutierrez-Perez, Cecilia and Adams, Emily M and Lightfoot, Jorge D and Poimenidou, Galini and Pavuluri, Chetan and Prajna, Venkatesh and Cramer, Robert A and Fuller, Kevin K},
title = {Propranolol is efficacious against Aspergillus and Fusarium corneal isolates in vitro and in a murine model of Aspergillus keratitis},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2025},
doi = {10.1128/aac.01664-24}
}
EUVIMED